Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Technology
Share your love
How to Deal with the Epithelial Herpetic Keratitis
Trifluridine eye drop, acyclovir (ACV) ointment, ganciclovir gel, and oral ACV are still the main therapeutic agents. Cryopreserved amniotic membrane has been recently used as an adjuvant treatment. Resistance to ACV has become a concerning issue. The animal models of…
What is Schirmer’s Test and How to Conduct it
In the dynamic landscape of ophthalmology, the evaluation of tear production holds a central position in understanding and managing a spectrum of ocular conditions. Among the various tools available, Schirmer’s Test, named after the pioneering German ophthalmologist Otto Schirmer, stands…
VSY Unveils Enova Advanced EDoF IOL at EPOMEC 2023
VSY Biotechnology, a leading company in ophthalmic innovations, made a notable presence at the 10th Evolving Practice of Ophthalmology Middle East Conference (EPOMEC 2023) in Dubai. The conference, held from 23-25 November, marked a significant moment for VSY Biotechnology as…
Role of Corneal Hysteresis in Glaucoma Risk Assessment
What is Corneal Hysteresis? Corneal hysteresis is a measure of the cornea’s ability to absorb and dissipate energy when subjected to stress, such as the pressure exerted within the eye. The cornea is the clear, dome-shaped front surface of the…
Ocutrx Unveils OcuLenz AR/XR Headset for Advanced AMD
Ocutrx Technologies has launched the OcuLenz AR/XR headset, a cutting-edge device specifically engineered to elevate visual clarity and redefine the possibilities for those with advanced age-related macular degeneration. The OcuLenz AR/XR headset distinguishes itself with its lightweight and user-friendly design.…
AMD Forecast: New Algorithm Offers 94% Accuracy
Researchers at Duke University have developed a computer program that can predict with 94% accuracy whether an individual’s age-related macular degeneration (AMD) will deteriorate within a year. The deep learning algorithm, featured in an article within JAMA Ophthalmology, evaluates comprehensive…
Blind Canvas Project by Ora and BlindCAN Film Festival
Ora and the BlindCAN Film Festival have jointly unveiled The Blind Canvas Project, an initiative that leverages the capabilities of storytelling and generative artificial intelligence (AI) to cultivate a more profound comprehension of the lives and narratives of individuals affected…
Bausch + Lomb Acquires Eye Drugs from Novartis
Bausch + Lomb has announced that it will acquire the dry eye drug Xiidra (lifitegrast ophthalmic solution) 5% from Novartis. Xiidra is an eye drop without steroids that has received specific approval for treating the signs and symptoms of dry…
VSY’s SVT Technology Secures Patent Grant in the US
Andreas C. Kühnel, Managing Director at VSY Biotechnology announced that the company’s innovative Sinusoidal Vision Technology (SVT®) has received its U.S. patent from the United States Patent and Trademark Office. This significant milestone is a testament to the company’s commitment…
Tiny Eye Implant: A Diabetes Treatment Option
In Sweden, researchers have created a microscale device designed for implantation in the eye, opening up new paths for cell-based treatments for conditions like diabetes. Developed by a team from KTH Royal Institute of Technology and Karolinska Institutet, this 3D-printed…